Italian Company Wins Patent Decision Against Purdue

Law360, New York (January 16, 2007, 12:00 AM EST) -- After an inquiry into a recent interference, the U.S. Patent and Trademark Office said Friday that Italian company Newron Pharmaceuticals SpA should hold the only patent for certain methods of pain treatment.

Newron’s patent was challenged by an application to reissue a patent owned by Purdue Neuroscience Co., a subsidiary of Purdue Pharma LP. The USPTO declared an interference between the two patents in January 2006.

Newron’s patent, U.S. Patent No. 6,306,903, was issued in October 2001. The patent describes certain “alpha-aminoamide derivatives” useful in treating...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.